कोविड-19
चीन के पहले कोविड-19 टीके को मिली मंजूरी, साइनोफार्मा ने किया है विकसित
वैश्विक स्तर पर कोविड-19 मामले 8.39 करोड़ हुए, अमेरिका की हालत पतली
'कोवैक्सीन' को नहीं मिली आपातकालीन उपयोग की मंजूरी, दोबारा मांगा डेटा
/newsnation/media/agency_attachments/logo-webp.webp)
/newsnation/media/post_attachments/images/2021/01/05/vaccinecorona-57.jpg)
/newsnation/media/post_attachments/images/2020/09/06/covid-19-test-69.jpg)
/newsnation/media/post_attachments/images/2021/01/03/vaccinecovid19-79.jpg)
/newsnation/media/post_attachments/images/2021/01/03/uscovid-62.jpg)
/newsnation/media/media_files/2026/02/06/amazon-banner-2-2026-02-06-15-01-05.jpeg)
/newsnation/media/post_attachments/images/2021/01/03/covaxin-trial-89.jpg)
/newsnation/media/post_attachments/images/2021/01/03/waterloo-bridge-32.jpg)
/newsnation/media/post_attachments/images/2021/01/03/odisha-schools-38.jpg)
/newsnation/media/post_attachments/images/2021/01/02/beirut-closed-shops-73.jpg)
/newsnation/media/post_attachments/images/2021/01/02/covaxin-81.jpg)
/newsnation/media/post_attachments/images/2021/01/01/red-ants-chutney-59.jpg)
